magtrieve(tm)
magtrieve(tm) structure
|
Common Name | magtrieve(tm) | ||
|---|---|---|---|---|
| CAS Number | 12018-01-8 | Molecular Weight | 83.995 | |
| Density | 4.85 g/mL at 25ºC(lit.) | Boiling Point | decomposes to Cr2O3℃ [KIR78] | |
| Molecular Formula | CrO2 | Melting Point | >375ºC (dec.)(lit.) | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS07 |
Signal Word | Warning | |
|
Eczema caused by magnetic tapes.
Am. J. Contact Dermatitis 12(4) , 221-2, (2001)
|
|
|
Externally triggered healing of a thermoreversible covalent network via self-limited hysteresis heating.
Adv. Mater. 22(25) , 2784-7, (2010)
|
|
|
Application of novel chromium dioxide magnetic particles to immunoassay development.
Clin. Chem. 33(9) , 1543-7, (1987) We have used chromium dioxide magnetic particles as the solid support in developing a series of immunological tests. The high surface area (greater than 40 m2/g) available on the magnetic particles and their easy dispersion throughout a solution allow for rap... |
|
|
Effects of inhaled chromium dioxide dust on rats exposed for two years.
Fundam. Appl. Toxicol. 10(1) , 125-45, (1988) Rats were exposed by inhalation to chromium dioxide (CrO2) dust at design concentrations of 0, 0.5 mg/m3 (stabilized and unstabilized, respectively), or 25 mg/m3 (stabilized) for 6 hr/day, 5 days/week for 2 years. No dust-exposure-related pathological changes... |
|
|
Inhalation toxicity of chromium dioxide dust to rats after two years exposure.
Sci. Total Environ. 86(1-2) , 83-108, (1989) Rats were exposed by inhalation to chromium dioxide (CrO2) dust at design concentrations of 0, 0.5 (stabilized and unstabilized, respectively) or 25 mg m-3 (stabilized) for 6 h day-1, 5 days week-1 for 2 years. No dust-exposure-related pathological changes we... |
|
|
Plasmodium berghei: in vivo efficacy of albendazole in different rodent models.
Exp. Parasitol. 88(2) , 154-6, (1998)
|
|
|
Tissue contents and subcellular distribution of chromium and other trace metals in experimental diabetic rats after intravenous injection of Cr 50-enriched stable isotopic tracer solution.
Metab. Clin. Exp. 50(10) , 1168-74, (2001) In order to study the metabolism of essential trace elements in diabetics, we studied alloxan-diabetic rats for the distribution patterns of chromium (Cr), cobalt (Co), iron (Fe), selenium (Se), and zinc (Zn) in the liver, kidney, pancreas, and testes, as wel... |
|
|
Use of MagniSep chromium dioxide particles in an immunoassay system.
Ann. Biol. Clin. (Paris.) 48(8) , 583-6, (1990) The use of chromium dioxide particles as a solid support for very sensitive and rapid immunoassays, is the result of the combination of large surface area (40 m2) and high protein uptake capacity (40 mg/g) allowing rapid capture kinetics and high binding capa... |
|
|
Automated assay specific for cyclosporine in whole blood, with use of a chromium dioxide particle column.
Clin. Chem. 35(9) , 1860-1, (1989)
|
|
|
Immobilization of antigens and antibodies on chromium dioxide magnetic particles for use in immunodiagnostic assays.
Targeted Diagn. Ther. 2 , 201-16, (1989)
|